Key Details
Last Dividend
$0.05Annual ROE
5.28%Beta
-Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 4, 2024Recent annual earnings:
Feb 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Oct 31, 2024Next split:
N/ARecent split:
Jul 29, 2014Analyst ratings
Recent major analysts updates
Screeners with ARC included
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Similar stocks
ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms Partnership with Lovell Government Services is providing commercial benefit, facilitating purchase through validated US government online purchasing platforms EINDHOVEN, the Netherlands, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities today announces it has secured the required approvals to enable Veterans Affairs (VA) and other government agencies to immediately purchase the ARC-EX System through federal procurement systems.
BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Association of Related Churches (ARC) is thrilled to announce the highly anticipated 2025 launch season, with over 30 new churches set to open their doors between January and March. These launches will span 15 U.S. states and seven countries, marking a dynamic expansion of the Association of Related Churches' mission to help couples and their teams establish life-giving churches around the globe. These church planters have spent valuable months and years p.
ARC Resources' Attachie project startup will significantly boost free cash flow. The project's size will dominate corporate growth. ARC Resources maximizes sales prices for production. This differentiates it from many U.S. producers.
UW Medicine and Next Steps Chicago both purchased systems in late December 2024 ARC-EX is the first and only FDA approved technology indicated to improve hand strength and sensation in people with spinal cord injury ARC-EX was named a 2024 TIME Magazine Best Invention EINDHOVEN, the Netherlands, Jan. 09, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the first commercial sales of its ARC-EX System in the United States.
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology shown to improve hand strength and sensation after chronic spinal cord injury ARC-EX System is an FDA Breakthrough Device and 2024 TIME Magazine Best Invention EINDHOVEN, the Netherlands, Dec. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced that it has received de novo classification and authorization to market its ARC-EX System from the US Food and Drug Administration (FDA).
BIRMINGHAM, Ala.--(BUSINESS WIRE)--On October 15, 2024, the Association of Related Churches (ARC) once again hosted a powerful and unifying Gather Conference. With 16 simultaneous events held across 12 U.S. cities and 4 Canadian locations, this year's conference attracted over 3,000 church leaders, pastors, staff, and volunteers, all of whom are deeply committed to building relationships and gaining valuable resources to support the growth and vitality of local churches. The ARC Gather Conferen.
PETACH TIKVA, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Nanox.ARC, a stationary X-ray system intended to produce tomographic images for general use including human musculoskeletal system, pulmonary, intra-abdominal, and paranasal sinus indications, adjunctive to conventional radiography, on adult patients.
Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke Funding also supports technology development of ARC-BCI System and ARC-IM Lead Approximately 15 million people worldwide experience a stroke each year EINDHOVEN, the Netherlands, Nov. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a grant from the European Innovation Council (EIC) to study the use of its investigational ARC-BCI Therapy to restore upper limb movement after subcortical stroke.
Aqua Metals Inc (NASDAQ:AQMS) reported third-quarter results, detailing progress in lithium recycling, financing initiatives, and preparations for its Sierra AquaRefining Campus (ARC) in Nevada. The company's pilot facility has maintained 24-hour operations, producing lithium carbonate at over 99.5% purity, and claims to be the only US recycler delivering kilogram-scale quantities of battery-grade recycled lithium carbonate, demonstrating its Li AquaRefining technology's scalability.
Attachie project, now online, is boosting ARC's production with premium-priced condensates, which, together with rising gas prices, more than doubling the 2025 FCF compared to 2024. Despite the recent rise in share price, ARC remains undervalued, with a price target in the range of C$30-35 (upside ~30%). LNG contracts are adding exposure to international gas pricing, potentially significantly boosting ARC's FCF.
FAQ
- What is the ticker symbol for ARC Document Solutions?
- Does ARC Document Solutions pay dividends?
- What sector is ARC Document Solutions in?
- What industry is ARC Document Solutions in?
- What country is ARC Document Solutions based in?
- When did ARC Document Solutions go public?
- Is ARC Document Solutions in the S&P 500?
- Is ARC Document Solutions in the NASDAQ 100?
- Is ARC Document Solutions in the Dow Jones?
- When was ARC Document Solutions's last earnings report?
- When does ARC Document Solutions report earnings?
- Should I buy ARC Document Solutions stock now?